SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 0-54717
BIONIK LABORATORIES CORP.
80 Coolidge Hill Road, Watertown, MA 02472
Common Stock, $0.001 par value per share
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|Rule 12h-3 (b)(1)(ii)||x|
Approximate number of holders of record as of the certification or notice date: 310
Pursuant to the requirements of the Securities Exchange Act of 1934, Bionik Laboratories Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Dated: June 30, 2023
|BIONIK LABORATORIES CORP.|
|By:||/s/ Rich Russo Jr.|
|Name: Rich Russo Jr.|
|Title: Chief Executive Officer|